Loading
HKSEHealthcareDrug Manufacturers - Specialty & Generic
Latest quote
HK$2.295
−HK$0.035 · -1.50%
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Latest quote
HK$2.295
−HK$0.035 · -1.50%
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Day range
Current HK$2.295
52-week range
Current HK$2.295
Historical prices · Market data may be delayed.
Jilin Province Huinan Changlong Bio-pharmacy Company Limited focuses on the manufacturing and sale of traditional Chinese medicines and various pharmaceutical products within the People's Republic of China. The company's extensive product portfolio includes a wide range of dosage forms such as tablets, capsules, and pills, as well as specialized items like Chinese medicine pretreatment and extraction products. They also provide various injectable solutions, including powders for injection, lyophilized powders for injection, and small volume liquid injections, along with active pharmaceutical ingredients (APIs) and granules. These products are primarily sold under the "Changlong" and "Qing Tong" brand names. Established in 1989, and headquartered in Kowloon, Hong Kong, the company was previously known as Jilin Province Huinan Biochemical Pharmaceutical Company Limited.
Day range
Current HK$2.295
52-week range
Current HK$2.295
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (CNY) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 901.87M CNY | 881.16M CNY | 841.55M CNY | 841.59M CNY | 705.46M CNY |
| Cost of goods sold | 144.2M CNY | 195.91M CNY | 257.5M CNY | 193.55M CNY | 125.45M CNY |
| Gross profit | 757.67M CNY | 685.25M CNY | 584.05M CNY | 648.04M CNY | 580.01M CNY |
| Research and development | — | — | 13.1M CNY | 19.06M CNY | 20.58M CNY |
| Selling, general, and administrative | 561.36M CNY | 522.19M CNY | 448.95M CNY | 509.95M CNY | 454M CNY |
| Operating expenses | 543.07M CNY | 476.06M CNY | 385.22M CNY | 450.21M CNY | 401.65M CNY |
| Interest income | 48.68M CNY | 18.76M CNY | 33.12M CNY | 35.31M CNY | 33.59M CNY |
| Interest expense | 1.39M CNY | 2.03M CNY | 515K CNY | 477K CNY | 344K CNY |
| Depreciation and amortization | 28.34M CNY | 27.14M CNY | 27.56M CNY | 33.6M CNY | 28.88M CNY |
| Operating income | 214.6M CNY | 209.19M CNY | 198.83M CNY | 197.82M CNY | 177.62M CNY |
| Net income | 198.88M CNY | 184.25M CNY | 148.21M CNY | 193.57M CNY | 143.28M CNY |
Company facts updated Sep 5, 2026.
Recent quarterly results
Recent quarterly results
Cash distributions grouped by calendar year; partial years are marked.
HK$0.2729
2025 complete year+279.9% since 2021
2026 partial: HK$0.2873
HK$0.0718
2,021
HK$0.0732
2,022
HK$0.5533
2,023
HK$0.0686
2,024
HK$0.2729
2,025
HK$0.2873
2,026*
* Partial calendar year in the available dividend history.
| Action | Ex-dividend date | Details | Record date | Payment date |
|---|---|---|---|---|
Dividend | Jun 22, 2026 | HK$0.2873Special | Jun 24, 2026 | Jul 10, 2026 |
Dividend | Jun 24, 2025 | HK$0.2729Special | Jun 26, 2025 | Jul 18, 2025 |
Dividend | Jun 18, 2024 | HK$0.0686Special | Jun 19, 2024 | Jul 16, 2024 |
Dividend | Jun 8, 2023 | HK$0.5533Special | Jun 9, 2023 | Jun 30, 2023 |
Dividend | Jul 26, 2022 | HK$0.0732Special | Jul 27, 2022 | Aug 31, 2022 |
Dividend | Oct 15, 2021 | HK$0.0316Special | Oct 18, 2021 | Nov 18, 2021 |
Ex-dividend Jun 22, 2026
HK$0.2873
Special
Record Jun 24, 2026 · Payment Jul 10, 2026
Ex-dividend Jun 24, 2025
HK$0.2729
Special
Record Jun 26, 2025 · Payment Jul 18, 2025
Ex-dividend Jun 18, 2024
HK$0.0686
Special
Record Jun 19, 2024 · Payment Jul 16, 2024
Ex-dividend Jun 8, 2023
HK$0.5533
Special
Record Jun 9, 2023 · Payment Jun 30, 2023
Ex-dividend Jul 26, 2022
HK$0.0732
Special
Record Jul 27, 2022 · Payment Aug 31, 2022
Ex-dividend Oct 15, 2021
HK$0.0316
Special
Record Oct 18, 2021 · Payment Nov 18, 2021
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
